Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of EUR 310.43 million. The enterprise value is 296.71 million.

Market Cap	310.43M
Enterprise Value	296.71M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	18.25M
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.60M

Valuation Ratios

The trailing PE ratio is 28.73 and the forward PE ratio is 28.00.

PE Ratio	28.73
Forward PE	28.00
PS Ratio	5.84
PB Ratio	7.57
P/TBV Ratio	8.76
P/FCF Ratio	26.39
P/OCF Ratio	25.25
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.78, with an EV/FCF ratio of 25.23.

EV / Earnings	27.46
EV / Sales	5.63
EV / EBITDA	18.78
EV / EBIT	21.51
EV / FCF	25.23

Financial Position

The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.

Current Ratio	3.91
Quick Ratio	2.52
Debt / Equity	0.06
Debt / EBITDA	0.14
Debt / FCF	0.20
Interest Coverage	194.08

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.

Return on Equity (ROE)	27.42%
Return on Assets (ROA)	17.26%
Return on Invested Capital (ROIC)	21.22%
Return on Capital Employed (ROCE)	31.82%
Revenue Per Employee	344,895
Profits Per Employee	70,174
Employee Count	154
Asset Turnover	1.05
Inventory Turnover	0.73

Taxes

In the past 12 months, Medistim ASA has paid 3.29 million in taxes.

Income Tax	3.29M
Effective Tax Rate	23.34%

Stock Price Statistics

The stock price has increased by +11.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.22%
50-Day Moving Average	16.24
200-Day Moving Average	14.27
Relative Strength Index (RSI)	53.69
Average Volume (20 Days)	183

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of EUR 53.11 million and earned 10.81 million in profits. Earnings per share was 0.59.

Revenue	53.11M
Gross Profit	42.62M
Operating Income	13.91M
Pretax Income	14.10M
Net Income	10.81M
EBITDA	15.16M
EBIT	13.91M
Earnings Per Share (EPS)	0.59

Full Income Statement

Balance Sheet

The company has 16.13 million in cash and 2.30 million in debt, giving a net cash position of 13.83 million.

Cash & Cash Equivalents	16.13M
Total Debt	2.30M
Net Cash	13.83M
Net Cash Per Share	n/a
Equity (Book Value)	41.02M
Book Value Per Share	2.25
Working Capital	30.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.30 million and capital expenditures -533,668, giving a free cash flow of 11.76 million.

Operating Cash Flow	12.30M
Capital Expenditures	-533,668
Free Cash Flow	11.76M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.

Gross Margin	80.25%
Operating Margin	26.19%
Pretax Margin	26.54%
Profit Margin	20.35%
EBITDA Margin	28.55%
EBIT Margin	26.19%
FCF Margin	22.15%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 3.04%.

Dividend Per Share	0.51
Dividend Yield	3.04%
Dividend Growth (YoY)	33.88%
Years of Dividend Growth	n/a
Payout Ratio	86.87%
Buyback Yield	-0.06%
Shareholder Yield	2.98%
Earnings Yield	3.48%
FCF Yield	3.79%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6